Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Italy

Drugmakers To Pay For Hospital Overspend?

June 2012 | Industry Trend Analysis

BMI View: We maintain our forecast of deteriorating prospects for drugmakers in Italy, as in addition to a decline in public spending on pharmaceuticals (enforced by price cuts on medicines), company revenue streams will remain under pressure as hospitals are delaying payments worth billions of dollars. Our bearish outlook takes into account the deteriorating state of the economy and the country's enormous public debt

To read the full article, please choose one of the following options:

Subcribers please log in

Western Europe InsightWestern Europe Channels Western Europe Countries